Tasly Pharmaceutical Group Co., Ltd. Announces Cash Dividend for 2018, Payable on June 13, 2019
June 04, 2019
Share
Tasly Pharmaceutical Group Co., Ltd. announced that the company implements the scheme of rights and interests distribution for 2018 with the differentiation scheme of dividend distribution, bonus shares and capitalization from capital public reserve as follows: a cash dividend of RMB 3.00 (tax included) per 10 shares on the basis of 1,507,919,530 shares (by excluding 4,746,699 shares repurchased on the special account of repurchase from total amount of 1,512,666,229 shares on the record date confirmed by the announcement on implementing profit distribution) and the total cash dividend of RMB 452,375,859.00 (tax included) distributed to all shareholders registered on the record date of the dividend distribution. Cash dividend payable date is on June 13, 2019, record date is on June 12, 2019 and ex-dividend date is on June 13, 2019.
Tasly Pharmaceutical Group Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main businesses include the manufacture and sales of traditional Chinese medicines, chemical preparations, chemical raw materials and biological medicines. The Company's main products include Compound Danshen Dropping Pills, Yangxuenao Granules, Yangxuenao Pills, Qishen Yiqi Dropping Pills, Diqing and Shuilinjia. Its products are used to treat cardiovascular and cerebrovascular diseases, tumors, colds, fevers and liver diseases. The Company mainly distributes its products in the domestic market.